HPCRF(HPCRF)
HPCRF
No analyst ratings available
No analyst price targets available for HPCRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $68.37B | $70.92B | $73.63B | $72.78B |
| Low | $65.88B | $67.78B | $70.66B | $69.84B |
| High | $70.52B | $74.05B | $76.43B | $75.55B |
| EBITDA Avg | $11.01B | $11.42B | $11.86B | $11.72B |
| Low | $10.61B | $10.91B | $11.38B | $11.25B |
| High | $11.35B | $11.92B | $12.31B | $12.16B |
| EBIT Avg | $7.68B | $7.97B | $8.27B | $8.18B |
| Low | $7.40B | $7.61B | $7.94B | $7.85B |
| High | $7.92B | $8.32B | $8.59B | $8.49B |
| Net Income Avg | $6.06B | $6.39B | $6.71B | $6.69B |
| Low | $5.75B | $6.05B | $6.36B | $6.34B |
| High | $6.36B | $6.70B | $7.04B | $7.02B |
| EPS Avg | $0.46 | $0.49 | $0.51 | $0.51 |
| Low | $0.44 | $0.46 | $0.49 | $0.49 |
| High | $0.49 | $0.51 | $0.54 | $0.54 |
| Analysts (Rev / EPS) | 15 / 1 | 15 / 1 | 6 / 1 | 11 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $16.51B | $16.51B |
| Low | $16.51B | $16.51B |
| High | $16.51B | $16.51B |
| EBITDA Avg | $2.66B | $2.66B |
| Low | $2.66B | $2.66B |
| High | $2.66B | $2.66B |
| EBIT Avg | $1.86B | $1.85B |
| Low | $1.86B | $1.85B |
| High | $1.86B | $1.85B |
| Net Income Avg | $1.33B | $1.86B |
| Low | $1.33B | $1.86B |
| High | $1.33B | $1.86B |
| EPS Avg | $0.10 | $0.14 |
| Low | $0.10 | $0.14 |
| High | $0.10 | $0.14 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |